| RS2145793028 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145793110 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145793644 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145793726 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145794013 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145794195 |
CHEK2
|
Health Risk |
Pathogenic |
Malignant tumor of breast, Hereditary cancer-predisposing syndrome |
| RS2145794314 |
SLC7A9
|
Health Risk |
Pathogenic |
— |
| RS2145794535 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145794545 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS2145794764 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2145795264 |
CACNA1G
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 42, Spinocerebellar ataxia type 42 |
| RS2145795692 |
WDR62
|
Health Risk |
Likely pathogenic |
Microcephaly 2, primary |
| RS2145795850 |
GP1BB
|
Health Risk |
Likely pathogenic |
Bernard Soulier syndrome, Bernard Soulier syndrome |
| RS2145796039 |
GP1BB
|
Health Risk |
Likely pathogenic |
— |
| RS2145796040 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145796172 |
GP1BB
|
Health Risk |
Likely pathogenic |
— |
| RS2145796221 |
GP1BB
|
Health Risk |
Pathogenic |
Bernard Soulier syndrome, Bernard Soulier syndrome |
| RS2145796512 |
GP1BB
|
Health Risk |
Likely pathogenic |
— |
| RS2145796556 |
GP1BB
|
Health Risk |
Pathogenic |
Bernard Soulier syndrome, Bernard Soulier syndrome |
| RS2145798387 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS2145801216 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145801350 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145801378 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145802334 |
ERBB2
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2145803112 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145803751 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2145804427 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145805017 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145805179 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2145806157 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, CHEK2-related cancer predisposition |
| RS2145806264 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2145806928 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145807103 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2145807398 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2145811711 |
ERBB2
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2145813286 |
GREB1L
|
Health Risk |
Likely pathogenic |
Hearing loss, autosomal dominant 80 |
| RS2145813505 |
ERBB2
|
Health Risk |
Pathogenic |
Visceral neuropathy, familial |
| RS2145814066 |
SON
|
Health Risk |
Pathogenic |
— |
| RS2145815261 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2145815434 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145815556 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145815692 |
ATP6V0A1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with epilepsy and brain atrophy, Neurodevelopmental disorder with epilepsy and brain atrophy |
| RS2145815915 |
CTSA
|
Health Risk |
Likely pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2145816035 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2145816053 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145816069 |
CTSA
|
Health Risk |
Pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2145816590 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2145816784 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2145817180 |
SON
|
Health Risk |
Pathogenic |
— |
| RS2145817185 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2145817523 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145817725 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145819152 |
CTSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined deficiency of sialidase AND beta galactosidase, Cathepsin a-related arteriopathy-strokes-leukoencephalopathy |
| RS2145819270 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2145820777 |
SON
|
Health Risk |
Pathogenic |
— |
| RS2145821217 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2145822607 |
KDM4B
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal dominant 65 |
| RS2145823461 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2145824370 |
CTSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2145824951 |
RNASEH2A
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 4, Aicardi-Goutieres syndrome 4 |
| RS2145824966 |
RAC2
|
Health Risk |
Pathogenic |
Immunodeficiency 73c with defective neutrophil chemotaxis and hypogammaglobulinemia, Immunodeficiency 73c with defective neutrophil chemotaxis and hypogammaglobulinemia |
| RS2145825232 |
CTSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2145825816 |
BRIP1
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2145825942 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145826394 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2145826423 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2145826463 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2145826750 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2145827538 |
ELMO2
|
Health Risk |
Pathogenic |
Primary intraosseous venous malformation, Primary intraosseous venous malformation |
| RS2145827552 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2145827836 |
TBX1
|
Health Risk |
Conflicting classifications of pathogenicity |
DiGeorge syndrome, Tetralogy of Fallot |
| RS2145827917 |
TBX1
|
Health Risk |
Pathogenic |
DiGeorge syndrome, Velocardiofacial syndrome |
| RS2145827929 |
TBX1
|
Health Risk |
Pathogenic |
DiGeorge syndrome, DiGeorge syndrome |
| RS2145828175 |
SON
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2145828204 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145828319 |
TBX1
|
Health Risk |
Likely pathogenic |
— |
| RS2145828435 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2145828926 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2145829352 |
SON
|
Health Risk |
Pathogenic |
— |
| RS2145829543 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2145829990 |
BRIP1
|
Health Risk |
Pathogenic |
— |
| RS2145830162 |
RNASEH2A
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 4, Aicardi-Goutieres syndrome 4 |
| RS2145830181 |
RNASEH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Aicardi-Goutieres syndrome 4, Aicardi-Goutieres syndrome 4 |
| RS2145830278 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145830843 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145831260 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2145831490 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2145831520 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS2145831560 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2145832543 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2145832569 |
TRIOBP
|
Health Risk |
Pathogenic |
— |
| RS2145833294 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2145833313 |
TRIOBP
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Autosomal recessive nonsyndromic hearing loss 28 |
| RS2145833327 |
TRIOBP
|
Health Risk |
Likely pathogenic |
— |
| RS2145833916 |
SON
|
Health Risk |
Pathogenic |
— |
| RS2145835194 |
TBX1
|
Health Risk |
Pathogenic |
DiGeorge syndrome, DiGeorge syndrome |
| RS2145835560 |
TRIOBP
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Autosomal recessive nonsyndromic hearing loss 28 |
| RS2145835587 |
SON
|
Health Risk |
Pathogenic |
— |
| RS2145836457 |
TBX1
|
Health Risk |
Pathogenic |
DiGeorge syndrome, DiGeorge syndrome |
| RS2145836461 |
TBX1
|
Health Risk |
Conflicting classifications of pathogenicity |
DiGeorge syndrome, DiGeorge syndrome |